UPDATE : Wednesday, January 17, 2018
Dizziness, headache added to precautions for Lixiana
Anti-blood clotting drug Lixiana (ingredient: edoxaban), manufactured by Da...
by Lee Hye-seon  |  2017-10-25 17:50
Korea’s high drug to medical expense ratio needs remedial steps
Korea’s ratio of drug cost to overall medical expense ratio is higher than ...
by Lee Han-soo  |  2017-10-25 10:37
Huons to proceed with phase 3 clinical trials for dry eye treatment
Huons said Tuesday it has received approval from the Ministry of Food and D...
by Lee Han-soo  |  2017-10-24 17:56
Drugmakers to adopt anti-bribery management system ‘ISO 37001’
Korean drugmakers have announced that they would introduce an international...
by Lee Hye-seon  |  2017-10-24 15:59
Roche Korea vows to put patients’ needs first
Roche Korea finalized and presented 39 action plans to realize patient-cent...
by Marian Chu  |  2017-10-24 11:11
GSK gets US approval for shingles vaccine
Following the heels of approval from the European regulatory authorities, G...
by Marian Chu  |  2017-10-24 10:15
Sanofi-Regeneron proves safety of cholesterol drug
Sanofi-Aventis Korea said Monday its cholesterol-lowering injection Praluen...
by Marian Chu  |  2017-10-23 15:32
Korean pharmaceuticals vie to preempt dry eye treatment market
Korean pharmaceutical companies are striving to develop new drugs to treat ...
by Lee Hye-seon  |  2017-10-23 15:31
Novartis Korea increases cost-effectiveness of psoriasis drug
Novartis Korea said Friday its first-in-class drug for severe plaque psoria...
by Marian Chu  |  2017-10-20 17:48
Bullous pemphigoid added to precautions for DPP-4 inhibitors
Antidiabetic drugs of dipeptidyl peptidase-4 (DPP-4) inhibitor series will ...
by Lee Hye-seon  |  2017-10-20 16:02
Roche Korea is Korea’s 8th-best employer this year
Three pharmaceutical companies have put their names on the list of best emp...
by Marian Chu  |  2017-10-20 13:31
AstraZeneca Korea denies rumors on stopping price talks
AstraZeneca Korea said Thursday it would continue pricing negotiations for ...
by Marian Chu  |  2017-10-20 11:46
GSK Korea says its HPV vaccine reaches 89% effectiveness
GlaxoSmithKline Korea said Thursday its human papillomavirus (HPV) vaccine ...
by Marian Chu  |  2017-10-19 15:56
Green Cross starts to develop high-dose flu vaccine for seniors
Green Cross said Thursday that it has received approval from the Ministry o...
by Lee Han-soo  |  2017-10-19 14:50
LG Chem launches Korea’s 1st combination drug for diabetes, dyslipidemia
LG Chem said Wednesday that it has launched Zemiro, a combination drug for ...
by Lee Han-soo  |  2017-10-19 14:43
FDA approves second CAR-T therapy to treat lymphoma
The U.S. Food and Drug Administration has approved a second CAR-T treatment...
by Marian Chu  |  2017-10-19 11:26
Will AstraZeneca pull lung cancer drug off Korean market?
A cancer patient took to the streets Wednesday to protest against AstraZene...
by Marian Chu  |  2017-10-18 17:52
Huons to go ahead with phase 3 clinical trial for Hutox
Huons Global said Tuesday that it has received approval from the Ministry o...
by Lee Han-soo  |  2017-10-18 16:12
‘Poziotinib effective for rare non-small-cell lung cancer’
Patients with rare EGFR exon 20 mutation, accounting for about 10 percent o...
by Lee Hye-seon  |  2017-10-18 15:45
Daewoong unveils clinical trial results of expectorants treatment
Daewoong Pharmaceuticals said Tuesday that it has published the results of ...
by Lee Han-soo  |  2017-10-18 14:09
Back to Top